MD1375Y - Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor - Google Patents
Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilorInfo
- Publication number
- MD1375Y MD1375Y MDS20190004A MD1375Y MD 1375 Y MD1375 Y MD 1375Y MD S20190004 A MDS20190004 A MD S20190004A MD 1375 Y MD1375 Y MD 1375Y
- Authority
- MD
- Moldova
- Prior art keywords
- articulations
- inflammatory diseases
- soft tissues
- treating inflammatory
- solution
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 210000004872 soft tissue Anatomy 0.000 title abstract 2
- UJRHNBBBWMFTKQ-UHFFFAOYSA-N CC(C)OP(O)O.CC(C)SC(N)=N.CC(C)SC(N)=N Chemical compound CC(C)OP(O)O.CC(C)SC(N)=N.CC(C)SC(N)=N UJRHNBBBWMFTKQ-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 1
- 229960001259 diclofenac Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Invenţia se referă la medicina experimentală şi farmacologia clinică şi poate fi utilizată pentru tratamentul afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor la animalele de laborator.Esenţa invenţiei constă în aceea, că la şobolani se administrează intraperitoneal unimomentan 10 mg/kg soluţie de izopropilfosfit-S-izopropilizotiuroniu şi 10 mg/kg soluţie de diclofenac.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190004A MD1375Z (ro) | 2019-01-22 | 2019-01-22 | Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20190004A MD1375Z (ro) | 2019-01-22 | 2019-01-22 | Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1375Y true MD1375Y (ro) | 2019-10-31 |
| MD1375Z MD1375Z (ro) | 2020-05-31 |
Family
ID=68424456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20190004A MD1375Z (ro) | 2019-01-22 | 2019-01-22 | Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1375Z (ro) |
-
2019
- 2019-01-22 MD MDS20190004A patent/MD1375Z/ro active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| MD1375Z (ro) | 2020-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018502634A1 (en) | Topical compositions of apremilast | |
| PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
| IN2015DN00376A (ro) | ||
| JOP20220069A1 (ar) | عوامل محللة لـ brd9 ثنائية الوظيفة وطرق لاستخدامها | |
| WO2011102684A3 (ko) | 태반 추출물을 포함하는 조성물 | |
| MX2024010140A (es) | Nuevos metodos. | |
| BRPI0819690B8 (pt) | uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas | |
| EA200870254A1 (ru) | Способ лечения воспалительных заболеваний | |
| EA202090276A1 (ru) | Фармацевтическая композиция для лечения анемии | |
| MX2022012079A (es) | Metodos y composiciones para mantener la salud renal. | |
| WO2016090024A3 (en) | Combination therapy for treatment of cancer | |
| MA56019A (fr) | Nouveaux composés et compositions pharmaceutiques associées pour le traitement de maladies | |
| BR112019017393A8 (pt) | Composição farmacêutica de evolocumab e seu uso, kit, método para preparar polipeptídeo de ligação a pcsk9 e método para formular polipeptídeo terapêutico | |
| MX2021000127A (es) | Formulaciones de un inhibidor de axl/mer. | |
| MX2021006724A (es) | Compuestos de halo-alilamina y uso de los mismos. | |
| WO2007081486A3 (en) | Oral administration of defensins to treat intestinal diseases | |
| MX2023005971A (es) | Metodos y composicion para las modificaciones de kras. | |
| MY193963A (en) | Composition for treating joint diseases and kit containing same | |
| MX2022004382A (es) | Metodos para promover la produccion de scfa por microbiota intestinal. | |
| MD1375Z (ro) | Metodă de tratament al afecţiunilor inflamatorii ale ţesuturilor moi şi articulaţiilor | |
| WO2016130518A3 (en) | Methods and compositions for treating muscle disease and disorders | |
| MX2020005238A (es) | Compuestos novedosos como inhibidores mpges-1. | |
| BR112014001503A2 (pt) | composições farmacêuticas compreendendo 4-bromo-n-(imidazolidin-2-ilideno)-1h-benzimidazol-5-amina para o tratamento de doenças de pele | |
| MX2022012001A (es) | Tratamiento preventivo de la migra?a. | |
| EP3876946A4 (en) | COMPOSITIONS AND METHODS FOR TREATMENT OF VIRGIN DISEASE AND CARDIOPULMONARY DISEASES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued |